Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2013
04/11/2013US20130090324 Novel prolylcarboxypeptidase inhibitors
04/11/2013US20130090323 Heterocyclic compounds and their uses
04/11/2013US20130090310 Compositions and methods for inhibition of the jak pathway
04/11/2013US20130089625 Compounds Useful as Inhibitors of ATR Kinase
04/11/2013US20130089624 Compounds Useful as Inhibitors of ATR Kinase
04/11/2013US20130089613 Compounds Having Activating Effect on Subtypes of Peroxisome Proliferator-Activated Receptors and its Preparation Method and Uses
04/11/2013US20130089518 Novel pyrimidine derivatives
04/11/2013US20130087768 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode
04/11/2013CA2851082A1 1,3-substituted azetidine pde10 inhibitors
04/11/2013CA2851037A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases
04/11/2013CA2850082A1 Ethynyl derivatives as mglur5 allosteric modulators
04/11/2013CA2850013A1 Herbicidal pyridazinone derivatives
04/10/2013EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist
04/10/2013EP2576543A1 Pyrazole compounds as sigma receptor inhibitors
04/10/2013EP2576536A2 Haematopoietic-prostaglandin d2 synthase inhibitors
04/10/2013EP2576520A1 Radiolabeled compounds and methods thereof
04/10/2013EP2576510A1 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
04/10/2013EP2576507A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
04/10/2013EP2575866A1 Inhibitors of hcv ns5a
04/10/2013EP2575465A1 Salts of raltegravir
04/10/2013CN1759114B Heterocyclic N-aryl carboxamides as cytokine inhibitors
04/10/2013CN103038218A Condensed ring pyridine compound
04/10/2013CN103030635A Biaryl heterocycle-substituted oxazolidinone antibacterial drug
04/10/2013CN103030634A Bicyclo-containing oxazolidinone antibiotics
04/10/2013CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device
04/10/2013CN101903353B Aminopyrazole derivatives
04/10/2013CN101801940B Substituted isoxazoline compound and pest control agent
04/09/2013US8415486 IAP inhibitors
04/09/2013US8415482 Proline derivatives
04/09/2013US8415477 Violet laser excitable dyes and their method of use
04/09/2013US8415469 Compounds and methods for kinase modulation, and indications therefor
04/09/2013US8415382 Substituted benzazoles and methods of their use as inhibitors of RAF Kinase
04/09/2013US8415379 Pyridines
04/09/2013US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents
04/09/2013US8415359 Phenylpyrrole derivative
04/09/2013US8415349 Dicycloazaalkane derivatives, preparation processes and medical uses thereof
04/09/2013US8415348 Nitrogenated derivatives of pancratistatin
04/09/2013US8415347 Substituted tetracyclic tetahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
04/09/2013US8415346 Inhibitors of Janus kinases
04/09/2013US8415343 Autoimmune diseases; antiinflammatory agents; antiproliferative agents; benzodiazepine compound
04/09/2013US8415340 Triazine kinase inhibitors
04/09/2013US8415310 Isoxazoline derivatives as antiparasitic agents
04/09/2013CA2531050C Pharmaceutical compounds
04/04/2013WO2013049726A2 Processes for making compounds useful as inhibitors of atr kinase
04/04/2013WO2013049722A1 Compounds useful as inhibitors of atr kinase
04/04/2013WO2013049720A1 Compounds useful as inhibitors of atr kinase
04/04/2013WO2013049719A1 Compounds useful as inhibitors of atr kinase
04/04/2013WO2013049686A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
04/04/2013WO2013049559A1 Pyridine derivatives
04/04/2013WO2013049250A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
04/04/2013WO2013049119A1 Selective nr2b antagonists
04/04/2013WO2013049104A1 Pyridinedione carboxamide inhibitors of endothelial lipase
04/04/2013WO2013048949A2 Selective nr2b antagonists
04/04/2013WO2013048942A1 Quinolinone carboxamide inhibitors of endothelial lipase
04/04/2013WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
04/04/2013WO2013047813A1 1,2,4-triazine-6-carboxamide derivative
04/04/2013WO2013047411A1 Novel triazine derivative and ultraviolet absorbent
04/04/2013WO2013046136A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
04/04/2013WO2013045516A1 Viral replication inhibitors
04/04/2013WO2013044865A1 Oxazolidinone antibiotics containing fused ring
04/04/2013WO2013044845A1 Biaryl heterocycle substituted oxazolidinon antibacterial drug
04/04/2013WO2013044816A1 Crystalline forms of azilsartan and preparation and uses thereof
04/04/2013WO2012177844A3 Substituted imidazopyridinyl-aminopyridine compounds
04/04/2013WO2012161622A3 Incretin hormone secretion stimulators, method for producing and using same
04/04/2013WO2011070179A8 Process for the preparation of propionic acid derivatives
04/04/2013US20130085275 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
04/04/2013US20130085150 Analogues for the treatment or prevention of flavivirus infections
04/04/2013US20130085148 Pyridine Derivatives
04/04/2013US20130085147 Hepatitis C Virus Inhibitors
04/04/2013US20130085140 Indenoisoquinolinone derivatives, manufacturing method and medical use thereof
04/04/2013US20130085138 Selective NR2B Antagonists
04/04/2013US20130085132 Pyrazole compound and pharmaceutical use thereof
04/04/2013US20130085131 Heterocyclic compounds and their uses
04/04/2013US20130085126 Pyrazole compounds
04/04/2013US20130084346 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
04/04/2013US20130081213 Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
04/04/2013CA2850566A1 Processes for making compounds useful as inhibitors of atr kinase
04/04/2013CA2850564A1 Compounds useful as inhibitors of atr kinase
04/04/2013CA2850551A1 Pyridine derivatives
04/04/2013CA2850367A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
04/04/2013CA2850166A1 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
04/04/2013CA2850003A1 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
04/04/2013CA2849995A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
04/04/2013CA2848604A1 Viral replication inhibitors
04/03/2013EP2574607A1 PDE10 modulators
04/03/2013CN103025731A 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors
04/03/2013CN103025730A Processes for preparing linezolid
04/03/2013CN103025728A 2,3,5-trisubstituted thiophene compounds and uses thereof
04/03/2013CN103025725A Hetero ring compound
04/03/2013CN103025724A 哌啶衍生物 Piperidine derivatives
04/03/2013CN103025721A Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and pharmaceutical composition comprising the same
04/03/2013CN103025716A Bicyclic compound derivatives and their use as acc inhibitors
04/03/2013CN103012390A Indole derivatives as S1P1 receptor
04/03/2013CN103012389A Rivaroxaban intermediate preparation method
04/03/2013CN103012388A Preparation methods for rivaroxaban and intermediate thereof, and intermediate compounds
04/03/2013CN103012387A Method for preparing iloperidone
04/03/2013CN103012378A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto
04/03/2013CN103012376A Amide derivatives
04/03/2013CN103012365A Preparation method of optical switch molecular compound based on diarylethene Schiff base
04/03/2013CN103012314A Sulfonamide compound and preparation method as well as application thereof
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 647